Metrics to compare | 688338 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688338PeersSector | |
|---|---|---|---|---|
P/E Ratio | 33.3x | 22.4x | −0.4x | |
PEG Ratio | −1.86 | −0.66 | 0.00 | |
Price/Book | 1.7x | 1.9x | 2.6x | |
Price / LTM Sales | 11.2x | 5.0x | 3.0x | |
Upside (Analyst Target) | - | 49.2% | 51.9% | |
Fair Value Upside | Unlock | 18.1% | 9.4% | Unlock |
Beijing Succeeder Technology Inc. engages in the research, development, production, and sales of testing instruments, reagents, and consumables in the field of in vitro diagnostics for thrombosis and hemostasis in China and internationally. The company offers coagulation testers, hemorheology testers, erythrocyte sedimentation rate and hematocrit testers, platelet aggregation testers, blood rheology analyzer, diagnostic reagents, and quality control products, as well as automated equipment with supporting testing instruments. Its products are used in the prevention, screening, diagnosis, and monitoring of thrombophilia and hemorrhagic diseases, such as stroke, coronary heart disease, and venous thromboembolism. Beijing Succeeder Technology Inc. was founded in 2003 and is based in Beijing, China.